Symposier - Sibutramine Safety and Obesity Treatment
Links shared publicly online about this topic.
- 897total visits
Symposier - Sibutramine Safety and Obesity Treatment
View full resource at symposier.com
Most Recently Shared on September 5, 2010 at 1:33 am By:
Dr. Stephan Rossner: Sibutramine Safety and Obesity Treatment. http://bit.ly/b0N3yX
Also Shared By:
Symposier - Obesity may play a role in poor breast cancer outcomes
symposier.com — “Uploaded and shared in Youtube by: mayoclinic — Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, according to a study presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium by Jennifer Crozier, M.D., a medical resident at Mayo Clinic Florida. "While other studies have looked at the effect of body weight on treatment outcome for estrogen receptor-positive breast cancer, no one has examined this” View full resource at symposier.com
Most Recently Shared on March 15, 2012 at 1:36 pm By:
Symposier Endocrino Health Site
Obesity may play a role in poor early-stage HER2-positive breast cancer outcomes, Mayo clinic http://t.co/1tmK20Eg
Symposier - Cardiologists and global chronic disease: Lessons from around the world
symposier.com — “Uploaded and shared in Youtube by: theheartorg — Join Dr Bob Harrington and fellows Dr Mark Huffman and Dr Jerry Bloomfield for a wide-ranging discussion on global chronic disease from diabetes and central obesity in India to the cardiovascular implications of HIV and HIV treatment in sub-Saharan Africa. For those inspired to follow in their footsteps, the panel reviews various training opportunities and the many advantages of working in global health.” View full resource at symposier.com
Most Recently Shared on October 27, 2011 at 1:54 am By:
Symposier Cardiology Cardiology and Health Business
Cardiologists and global chronic disease: Lessons from around the world http://t.co/30TArV0i
Symposier - Sugar Highs and Lows: Sugar on the Brain
symposier.com — “Uploaded and shared in Youtube by: UCtelevision — Neuroscience at the University of Michigan, Ann Arbor, discusses his lab's research into fundamental question about the brain and behavior. He discusses how food pleasure is generated in the brain, the neural bases of wanting and liking, and how fear and stress relate to desire. Series: "UCSF Center for Obesity, Assessment, Study and Treatment" [7/2011] [Health and Medicine] [Professional Medical Education] [Show ID: 21689]” View full resource at symposier.com
Most Recently Shared on August 1, 2011 at 9:22 pm By:
Symposier Endocrino Health Site
Sugar Highs and Lows: Sugar on the Brain, Kent Berridge, Professor of Psychology and Neuroscience. http://bit.ly/ngh6i1
Symposier - Dr Kisfalvi Speaks on Anti-Diabetic Therapy in the Treatment of Pancreatic Cancer
symposier.com — “Uploaded and shared in Youtube by: HirshbergFoundation — A large number of epidemiological studies linked long-standing type 2 diabetes (DM2), obesity, and metabolic syndrome with increased risk for developing a variety of cancers. Pancreatic cancer is well documented to be associated with DM2 and up to 80% of pancreatic cancer patients have overt DM2 or impaired glucose intolerance. Overt DM2 is characterized by hyperglycemia, hyperinsulinaemia and high insulin-like-growth-factor-1 (IGF-1), and” View full resource at symposier.com
Most Recently Shared on June 24, 2011 at 9:49 am By:
Symposier Endocrino Health Site
Dr Kisfalvi Speaks on Anti-Diabetic Therapy in the Treatment of Pancreatic Cancer. http://t.co/a3icCHd
A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Typ
onlinelibrary.wiley.com — “A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Type 2 Diabetes Mellitus Patients. - Borges - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 19, 2011 at 8:20 am By:
A Randomized, Parallel Group, Doubleâ€*blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (... http://bit.ly/kxWgY1
A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Typ
onlinelibrary.wiley.com — “A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Type 2 Diabetes Mellitus Patients. - Borges - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 19, 2011 at 8:19 am By:
A Randomized, Parallel Group, Doubleâ€*blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (... http://bit.ly/lDWJXI
A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Typ
onlinelibrary.wiley.com — “A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Type 2 Diabetes Mellitus Patients. - Borges - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 18, 2011 at 8:41 pm By:
Endocrinology Wisdom OW Health
A Randomized, Parallel Group, Doubleâ€*blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (... http://bit.ly/iAAVeh
Encouraging results from ReShape Duo Phase 1 study for treatment of obesity
news-medical.net — “ReShape Medical, Inc. today announces results of its U.S. Phase 1 investigational clinical study. This feasibility study of thirty subjects assessed the safety and effectiveness of the ReShape Duo in conjunction with lifestyle modification in patients with a body mass index of 30-40.” View full resource at news-medical.net
Most Recently Shared on June 17, 2011 at 12:24 pm By:
Obesity News: Encouraging results from ReShape Duo Phase 1 study for treatment of obesity: ReShape Medical, In... http://twurl.nl/16zbyp
Symposier - Sleeve gastrectomy for the treatment of the obesity by Single Port
symposier.com — “Uploaded and shared in Youtube by: isaacwalkerabreu — Sleeve gastrectomy for the treatment of the obesity by Single Port -- Gastrectomia vertical para tratamento da obesidade por Single Port.” View full resource at symposier.com
Most Recently Shared on May 24, 2011 at 10:24 pm By:
Symposier Endocrino Health Site
Sleeve gastrectomy for the treatment of the obesity by Single Port. http://bit.ly/fPMJk6
Symposier - Breakthrough Research and Treatments in Obesity and Diabetes
symposier.com — “Uploaded and shared in Youtube by: WCMCnews --" Told by Louis J. Aronne, M.D. Clinical Professor of Medicine Director of the Comprehensive Weight Control Program at Weill Cornell Medical Center Running Time: 6 minutes” View full resource at symposier.com
Most Recently Shared on April 29, 2011 at 1:13 am By:
Symposier Endocrino Health Site
Breakthrough Research and Treatments in Obesity and Diabetes. http://bit.ly/l9D3ic
Amylin, Takeda Halt Obesity Drug Study | Markets | Minyanville.com
minyanville.com — “There's yet another safety concern over an obesity treatment: Amylin and Takeda suspend human testing.” View full resource at minyanville.com
Most Recently Shared on March 16, 2011 at 4:46 pm By:
Amylin's Diet Drug Crumbles http://bit.ly/hOjLam
Manufacturers suspend study of investigational obesity drug combo
endocrinetoday.com — “A phase 2 study designed to explore the safety and efficacy of pramlintide/metreleptin, an investigational combination therapy for the treatment” View full resource at endocrinetoday.com
Most Recently Shared on March 16, 2011 at 3:40 pm By:
Manufacturers suspend study of investigational obesity drug combo http://bit.ly/fXq0oO
Symposier - ESC Congress 2010 by topic: from genes to CV outcomes
symposier.com — “Uploaded and shared in Youtube by: escardiodotorg " ESC 2010 Congress Spotlight by Fausto Pinto, CPC Chairman Impact of genotype on outcomes in the CURE ACTIVE study (Efficacy and Safety of Clopidogrel compared with Placebo according to CYP2C19 Genotype in over 6000 patients with Non-ST-elevation Acute Coronary Syndromes and atrial fibrillation) (Guillaume Par, Hamilton) Genetic profiling: ready for clinical use? (Gilles Montalescot, Paris) Genetic determinants of treatment benefit of ACE-inhibi” View full resource at symposier.com
Most Recently Shared on September 27, 2010 at 10:58 pm By:
Symposier Cardiology Cardiology and Health Business
ESC Congress 2010 by topic: from genes to CV outcomes. http://bit.ly/ccYuWW
Sound Medicine: August 15, 2010
soundmedicine.iu.edu — “Sound Medicine:August 15, 2010. Sound Medicine 08-15-10, Young Athletes & Hydration, High Birth-Weight & Obesity, Uninsured Have Higher Death Rates, Fewer County Health Officials, Physical Stimuli Can Prevent Strokes, Helping Babies Breathe, Safety of Anime Contact Lenses, . Listen to Sound Medicine, the weekly talk radio show sponsored by the IU School of Medicine and WFYI, 90.1 FM, the Indianapolis NPR affiliate.” View full resource at soundmedicine.iu.edu
Most Recently Shared on August 16, 2010 at 4:48 pm By:
STOP Sports Injuries Health Organization
Dr. Marj Albohm (@NATA1950 President) talks heat illness prevention and treatment with @SoundMedicine http://bit.ly/9ogBV1 #sports #safety
Symposier - The Prevention and the Treatment of Obesity
symposier.com — “Uploaded and shared in Youtube by: StanfordUniversity " John Morton and Thomas Robinson present two different perspectives on the issue of obesity in the United States. Their different occupations allows them to present different solutions to the problem that exists. During the final quarter of the Stanford Mini Med School, some of the most timely and important topics in contemporary medicine and the biosciences are addressed. Stanford Mini Med School is a series arranged and directed by Stanfor” View full resource at symposier.com
Most Recently Shared on July 16, 2010 at 6:58 pm By:
Symposier Endocrino Health Site
John Morton and Thomas Robinson - The Prevention and the Treatment of Obesity. http://bit.ly/cuFRq9
Advertisement
Symposier Cardiology
@SympoCardiology
ESC Congress 2010 by topic: from genes to CV outcomes. http://t.co/IaO0skpp
1 year ago...